Delivery Order SPE2DB20D9214-SPE2DB24FD4XN

Award Date 9/27/24
Potential Completion Date 10/21/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,634.90 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with an ultimate completion date of October 31, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
This federal contract award, valued at $5,634.90, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm-fixed-price delivery order for the supply of YF-VAX 1-dose vials, with a performance period through October 10, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,323.00 firm fixed-price delivery order under contract SPE2DB22FL0H1 is for the supply of YF-VAX 1 dose vials and has an ultimate completion date of January 12, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $5,634.90 for the supply of YF-VAX 1 dose vials. The contract is a firm fixed-price agreement with an ultimate completion date of October 11, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $32,501.15 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of YF-VAX, a 1 dose vial vaccine, with a period of performance through August 8, 2024. This award is part of DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,567.10 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with a performance period ending on February 10, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,817.45, is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of August 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,777.72 contract is for the supply of YF-VAX 1 dose vials and has an ultimate completion date of September 4, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,567.10 firm fixed-price delivery order is for the supply of YF-VAX 1 DOSE VIALS, a specialized pharmaceutical product, with an ultimate completion date of December 26, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,634.90 firm fixed-price delivery order contract is for the supply of YF-VAX 1 dose vials, with a period of performance through August 19, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4XN
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,634.90 delivery order is for the supply of YF-VAX 1 dose vials and has a firm fixed-price pricing structure with an ultimate completion date of October 21, 2024.

DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This award complements DMS Pharmaceutical Group's other prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 12/27/24, 9:26 AM